Variant report

Variant	rs2779208
Chromosome Location	chr17:15871208-15871209
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr17:15869541..15871982-chr17:15871991..15874515,2	K562	blood:

Extended variants
information (count: 88 )
Associated
traits (count: 12 )

rSNPs within LD-proxies of this variant (count:71)

rs_ID	r²[population]
rs1045599	0.89[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs1075901	0.84[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs11078320	0.88[AMR][1000 genomes];0.84[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs11078327	0.80[AMR][1000 genomes];0.89[EUR][1000 genomes]
rs11078331	0.88[EUR][1000 genomes]
rs11652025	0.89[EUR][1000 genomes]
rs11654	0.90[AMR][1000 genomes];0.94[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs11655456	0.90[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs11656046	0.90[EUR][1000 genomes]
rs11657160	0.84[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs11869450	0.89[AMR][1000 genomes];0.88[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs11869563	0.90[AMR][1000 genomes];0.90[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs12945463	0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs1860643	0.89[AMR][1000 genomes];0.86[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs1860644	0.83[AMR][1000 genomes];0.87[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs1860645	0.83[AMR][1000 genomes];0.87[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs2015353	0.81[EUR][1000 genomes]
rs2078050	0.87[EUR][1000 genomes]
rs2109632	0.89[AMR][1000 genomes];0.92[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs2157990	0.83[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs2157991	0.89[EUR][1000 genomes]
rs2159643	0.90[AMR][1000 genomes];0.92[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs2285582	0.83[AMR][1000 genomes];0.89[EUR][1000 genomes]
rs2285583	0.86[AMR][1000 genomes];0.87[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs2286795	0.83[AFR][1000 genomes];0.95[AMR][1000 genomes];0.93[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2286796	0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2535614	0.89[AMR][1000 genomes];0.91[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs2779207	0.92[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2779210	0.85[AMR][1000 genomes];0.89[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs2779211	0.80[EUR][1000 genomes]
rs2779212	0.88[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs35168566	0.85[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs3760297	0.83[AMR][1000 genomes];0.89[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs3785628	0.83[AMR][1000 genomes];0.89[EUR][1000 genomes]
rs3785629	0.84[EUR][1000 genomes]
rs4435297	0.81[AMR][1000 genomes];0.87[EUR][1000 genomes]
rs4792707	0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs4792708	0.88[AMR][1000 genomes];0.87[EUR][1000 genomes]
rs4792709	0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs4792712	0.88[AMR][1000 genomes];0.89[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs4792713	0.83[AMR][1000 genomes];0.89[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs4792715	0.89[AMR][1000 genomes];0.88[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs4792716	0.84[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs4792717	0.83[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs4792718	0.87[AMR][1000 genomes];0.87[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs6416868	0.89[AMR][1000 genomes];0.88[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs6502479	0.90[AMR][1000 genomes];0.88[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs6502480	0.83[AMR][1000 genomes];0.86[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs6502482	0.81[AMR][1000 genomes];0.91[EUR][1000 genomes]
rs6502488	0.86[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs7209094	0.90[AMR][1000 genomes];0.89[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs7210655	0.90[AMR][1000 genomes];0.89[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs7214695	0.80[EUR][1000 genomes]
rs7216949	0.90[AMR][1000 genomes];0.90[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs7223346	0.87[EUR][1000 genomes]
rs8064702	0.87[EUR][1000 genomes]
rs8065190	0.83[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs8066902	0.81[AMR][1000 genomes];0.81[EUR][1000 genomes]
rs8070859	0.90[AMR][1000 genomes];0.90[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs8075345	0.88[AMR][1000 genomes];0.87[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs8076669	0.80[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs8080221	0.87[AMR][1000 genomes];0.87[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs8081406	0.81[AMR][1000 genomes];0.89[EUR][1000 genomes]
rs8081667	0.85[EUR][1000 genomes]
rs9652827	0.83[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs9709250	0.89[EUR][1000 genomes]
rs9891938	0.83[AMR][1000 genomes];0.86[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs9896441	0.88[EUR][1000 genomes]
rs9897542	0.83[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs9899995	0.88[AMR][1000 genomes];0.88[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs9916868	0.83[AMR][1000 genomes];0.90[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:17 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv934185	chr17:15552960-16551197	ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	190 gene(s)	inside rSNPs	diseases
2	nsv1062951	chr17:15561070-15890644	Weak transcription Strong transcription Active TSS ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
3	nsv1066023	chr17:15607267-16053512	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	49 gene(s)	inside rSNPs	diseases
4	esv3330182	chr17:15652014-16569534	Strong transcription Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	177 gene(s)	inside rSNPs	diseases
5	esv3446844	chr17:15654843-16572246	Enhancers Strong transcription Flanking Active TSS Weak transcription ZNF genes & repeats Genic enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	177 gene(s)	inside rSNPs	diseases
6	nsv1061222	chr17:15672934-15999778	ZNF genes & repeats Weak transcription Enhancers Active TSS Bivalent Enhancer Strong transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
7	nsv907706	chr17:15731923-16056442	ZNF genes & repeats Weak transcription Enhancers Active TSS Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
8	nsv1067555	chr17:15804228-16001117	Weak transcription Flanking Active TSS Strong transcription Bivalent/Poised TSS Enhancers Active TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	33 gene(s)	inside rSNPs	diseases
9	nsv1063459	chr17:15804228-16543593	Weak transcription Flanking Active TSS Genic enhancers Enhancers ZNF genes & repeats Strong transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	164 gene(s)	inside rSNPs	diseases
10	nsv907707	chr17:15846535-15950751	Strong transcription Weak transcription Active TSS ZNF genes & repeats Enhancers Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	31 gene(s)	inside rSNPs	diseases
11	nsv907709	chr17:15851196-15937487	Weak transcription Genic enhancers Strong transcription Active TSS ZNF genes & repeats Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
12	nsv907708	chr17:15851196-15950751	Genic enhancers Weak transcription Strong transcription Enhancers Flanking Active TSS ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases
13	nsv1057493	chr17:15852125-15930718	Transcr. at gene 5' and 3' Weak transcription Strong transcription Genic enhancers Active TSS Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
14	nsv543215	chr17:15852125-15930718	Enhancers Bivalent Enhancer Weak transcription Genic enhancers Active TSS Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
15	nsv907710	chr17:15854257-15950751	Enhancers Weak transcription Genic enhancers Strong transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases
16	nsv1062220	chr17:15869557-16093156	Genic enhancers Active TSS Weak transcription Strong transcription ZNF genes & repeats Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	36 gene(s)	inside rSNPs	diseases
17	nsv1064878	chr17:15869557-16097241	Strong transcription Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	36 gene(s)	inside rSNPs	diseases

mRNA abundance (count:12)

SNP	Gene	Cis/trans	Tissue	Source
rs2779208	ADORA2B	cis	Heart Left Ventricle	GTEx
rs2779208	ADORA2B	cis	Artery Tibial	GTEx
rs2779208	ZSWIM7	cis	Muscle Skeletal	GTEx
rs2779208	TTC19	Cis_1M	lymphoblastoid	RTeQTL
rs2779208	ADORA2B	cis	Adipose Subcutaneous	GTEx
rs2779208	ADORA2B	cis	Muscle Skeletal	GTEx
rs2779208	ADORA2B	cis	Thyroid	GTEx
rs2779208	ADORA2B	cis	Nerve Tibial	GTEx
rs2779208	CENPV	cis	Artery Tibial	GTEx
rs2779208	ADORA2B	cis	Esophagus Muscularis	GTEx
rs2779208	ADORA2B	cis	lung	GTEx
rs2779208	ZSWIM7	Cis_1M	lymphoblastoid	RTeQTL

Chromatin state (count:107 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:15866400-15871800	Enhancers	NH-A	brain
2	chr17:15867400-15878000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
3	chr17:15868400-15871400	Enhancers	Hela-S3	cervix
4	chr17:15868400-15871400	Enhancers	NHDF-Ad	bronchial
5	chr17:15868400-15871600	Enhancers	Breast Myoepithelial Primary Cells	Breast
6	chr17:15868600-15871400	Enhancers	Sigmoid Colon	Sigmoid Colon
7	chr17:15868600-15871600	Enhancers	Dnd41	blood
8	chr17:15868600-15871800	Enhancers	Primary hematopoietic stem cells	blood
9	chr17:15868600-15872000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr17:15868600-15872000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
11	chr17:15868600-15872200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
12	chr17:15868600-15872400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr17:15868600-15872400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
14	chr17:15868600-15872400	Enhancers	K562	blood
15	chr17:15868800-15871400	Enhancers	Fetal Muscle Leg	muscle
16	chr17:15868800-15880000	Weak transcription	Brain Inferior Temporal Lobe	brain
17	chr17:15869000-15875800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr17:15869200-15871600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
19	chr17:15869400-15871800	Enhancers	Primary T helper cells PMA-I stimulated	--
20	chr17:15869600-15871400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
21	chr17:15869800-15872200	Enhancers	Liver	Liver
22	chr17:15870200-15871400	Genic enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
23	chr17:15870200-15871600	Enhancers	Thymus	Thymus
24	chr17:15870200-15871800	Enhancers	Primary T helper naive cells from peripheral blood	blood
25	chr17:15870200-15872600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
26	chr17:15870200-15879600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
27	chr17:15870200-15880200	Weak transcription	Primary B cells from peripheral blood	blood
28	chr17:15870200-15883600	Weak transcription	Fetal Heart	heart
29	chr17:15870400-15871400	Enhancers	H1 Cell Line	embryonic stem cell
30	chr17:15870400-15871400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
31	chr17:15870400-15871400	Genic enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
32	chr17:15870400-15871600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
33	chr17:15870400-15871800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr17:15870400-15872000	Enhancers	Cortex derived primary cultured neurospheres	brain
35	chr17:15870400-15872400	Enhancers	iPS-18 Cell Line	embryonic stem cell
36	chr17:15870400-15872400	Enhancers	Rectal Mucosa Donor 31	rectum
37	chr17:15870400-15874000	Weak transcription	HSMMtube	muscle
38	chr17:15870400-15874200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr17:15870400-15874200	Weak transcription	Placenta Amnion	Placenta Amnion
40	chr17:15870400-15877600	Weak transcription	Fetal Brain Female	brain
41	chr17:15870400-15877600	Weak transcription	Skeletal Muscle Female	skeletal muscle
42	chr17:15870400-15877800	Weak transcription	Adipose Nuclei	Adipose
43	chr17:15870400-15877800	Weak transcription	Duodenum Smooth Muscle	Duodenum
44	chr17:15870400-15877800	Weak transcription	Left Ventricle	heart
45	chr17:15870400-15878000	Weak transcription	Fetal Lung	lung
46	chr17:15870400-15878000	Weak transcription	Fetal Stomach	stomach
47	chr17:15870400-15878000	Weak transcription	A549	lung
48	chr17:15870400-15878200	Weak transcription	Osteobl	bone
49	chr17:15870400-15879600	Weak transcription	Brain Anterior Caudate	brain
50	chr17:15870400-15880000	Weak transcription	Brain Germinal Matrix	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links